Calculated Parameters of Thyroid Homeostasis: Emerging Tools for Differential Diagnosis and Clinical Research

Although technical problems of thyroid testing have largely been resolved by modern assay technology, biological variation remains a challenge. This applies to subclinical thyroid disease, non-thyroidal illness syndrome, and those 10% of hypothyroid patients, who report impaired quality of life, despite normal thyrotropin (TSH) concentrations under levothyroxine (L-T4) replacement. Among multiple explanations for this condition, inadequate treatment dosage and monotherapy with L-T4 in subjects with impaired deiodination have received major attention. Translation to clinical practice is difficult, however, since univariate reference ranges for TSH and thyroid hormones fail to deliver robust decision algorithms for therapeutic interventions in patients with more subtle thyroid dysfunctions. Advances in mathematical and simulative modeling of pituitary–thyroid feedback control have improved our understanding of physiological mechanisms governing the homeostatic behavior. From multiple cybernetic models developed since 1956, four examples have also been translated to applications in medical decision-making and clinical trials. Structure parameters representing fundamental properties of the processing structure include the calculated secretory capacity of the thyroid gland (SPINA-GT), sum activity of peripheral deiodinases (SPINA-GD) and Jostel’s TSH index for assessment of thyrotropic pituitary function, supplemented by a recently published algorithm for reconstructing the personal set point of thyroid homeostasis. In addition, a family of integrated models (University of California-Los Angeles platform) provides advanced methods for bioequivalence studies. This perspective article delivers an overview of current clinical research on the basis of mathematical thyroid models. In addition to a summary of large clinical trials, it provides previously unpublished results of validation studies based on simulation and clinical samples.

[1]  D. Girelli,et al.  Low selenium status in the elderly influences thyroid hormones. , 1995, Clinical science.

[2]  O. Koulouri,et al.  Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under‐replacement with levothyroxine , 2011, Clinical endocrinology.

[3]  J. DiStefano,et al.  TSH-based protocol, tablet instability, and absorption effects on L-T4 bioequivalence. , 2009, Thyroid : official journal of the American Thyroid Association.

[4]  Johannes W. Dietrich,et al.  Variation in the biochemical response to l-thyroxine therapy and relationship with peripheral thyroid hormone conversion efficiency , 2015, Endocrine connections.

[5]  S. Shalet,et al.  The use of thyroid function tests in the diagnosis of hypopituitarism: definition and evaluation of the TSH Index , 2009, Clinical endocrinology.

[6]  J. W. Dietrich,et al.  THYROTROPIC FEEDBACK CONTROL: EVIDENCE FOR AN ADDITIONAL ULTRASHORT FEEDBACK LOOP FROM FRACTAL ANALYSIS , 2004, Cybern. Syst..

[7]  R. Utiger,et al.  Regulation of the pituitary-thyroid axis in man: relationship of TSH concentration to concentration of free and total thyroxine in plasma. , 1967, The Journal of clinical endocrinology and metabolism.

[8]  Ho-Cheol Kang,et al.  A case of masked toxic adenoma in a patient with non-thyroidal illness , 2014, BMC Endocrine Disorders.

[9]  Orit Shechtman,et al.  The Coefficient of Variation as an Index of Measurement Reliability , 2013 .

[10]  P. Scriba,et al.  Normalisierung des T3/T4-Quotienten im Serum bei Struma-Patienten unter Kaliumjodid: Ein Beispiel der Autoregulation der Schilddrüse , 2005, Klinische Wochenschrift.

[11]  A. Miyauchi,et al.  Ratio of serum free triiodothyronine to free thyroxine in Graves' hyperthyroidism and thyrotoxicosis caused by painless thyroiditis. , 2005, Endocrine journal.

[12]  H. Liu,et al.  Metabolic Characteristics in Obese Patients Complicated by Mild Thyroid Hormone Deficiency , 2016, Hormone and Metabolic Research.

[13]  Melvin Khee-Shing Leow,et al.  A novel minimal mathematical model of the hypothalamus-pituitary-thyroid axis validated for individualized clinical applications. , 2014, Mathematical biosciences.

[14]  Johannes W. Dietrich,et al.  TSH and Thyrotropic Agonists: Key Actors in Thyroid Homeostasis , 2012, Journal of thyroid research.

[15]  H. Candiloros,et al.  The serum triiodothyronine to thyroxine (T3/T4) ratio in various thyroid disorders and after Levothyroxine replacement therapy. , 2004, Hormones.

[16]  P. Laurberg,et al.  Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. , 2002, The Journal of clinical endocrinology and metabolism.

[17]  Jie-shou Li,et al.  Nonthyroidal Illness Syndrome: Is It Far Away From Crohn’s Disease? , 2013, Journal of clinical gastroenterology.

[18]  C. Spencer,et al.  Current status and performance goals for serum thyrotropin (TSH) assays. , 1996, Clinical chemistry.

[19]  Johannes W. Dietrich,et al.  Homeostatic Control of the Thyroid–Pituitary Axis: Perspectives for Diagnosis and Treatment , 2015, Front. Endocrinol..

[20]  K. Burman,et al.  Subclinical hyperthyroidism: controversies in management. , 2002, American family physician.

[21]  R. Hoermann,et al.  Reference range for thyrotropin , 2015, Nuklearmedizin.

[22]  P. Walfish T3/T4 RATIO IN THYROID DISEASE , 1978, The Lancet.

[23]  L. Wartofsky Levothyroxine: therapeutic use and regulatory issues related to bioequivalence , 2002, Expert opinion on pharmacotherapy.

[24]  J. DiStefano,et al.  TSH regulation dynamics in central and extreme primary hypothyroidism. , 2010, Thyroid : official journal of the American Thyroid Association.

[25]  F. Frasca,et al.  Levothyroxine Monotherapy Cannot Guarantee Euthyroidism in All Athyreotic Patients , 2011, PloS one.

[26]  N. Amino,et al.  T3/T4 RATIO IN THYROID DISEASE , 1979, The Lancet.

[27]  K. Pantalone,et al.  Approach to a low TSH level: Patience is a virtue , 2010, Cleveland Clinic Journal of Medicine.

[28]  A. Villringer,et al.  Patient-reported outcomes in adequately treated hypothyroidism – insights from the German versions of ThyDQoL, ThySRQ and ThyTSQ , 2013, Health and Quality of Life Outcomes.

[29]  Johannes W. Dietrich,et al.  Derivation of a multivariate reference range for pituitary thyrotropin and thyroid hormones: diagnostic efficiency compared with conventional single-reference method. , 2016, European journal of endocrinology.

[30]  J. DiStefano,et al.  On model and data requirements for determining the bioavailability of oral therapeutic agents: application to gut absorption of thyroid hormones. , 1979, The American journal of physiology.

[31]  Johannes W. Dietrich,et al.  Of rats and men: thyroid homeostasis in rodents and human beings. , 2015, The lancet. Diabetes & endocrinology.

[32]  H. Pijl,et al.  Human longevity is characterised by high thyroid stimulating hormone secretion without altered energy metabolism , 2015, Scientific Reports.

[33]  C. Randall Letter: Temporary paralysis in childhood after influenza B. , 1975, Lancet.

[34]  Johannes W. Dietrich,et al.  Homeostatic equilibria between free thyroid hormones and pituitary thyrotropin are modulated by various influences including age, body mass index and treatment , 2014, Clinical endocrinology.

[35]  Johannes W. Dietrich,et al.  Nonthyroidal Illness Syndrome in Cardiac Illness Involves Elevated Concentrations of 3,5-Diiodothyronine and Correlates with Atrial Remodeling , 2015, European Thyroid Journal.

[36]  A. Rydzewski,et al.  Influence of low protein diet on nonthyroidal illness syndrome in chronic renal failure , 2005, Endocrine.

[37]  C. Dayan,et al.  Hypothyroidism and Depression , 2013, European Thyroid Journal.

[38]  R Bianchi,et al.  Thyroidal and peripheral production of 3,5,3'-triiodothyronine in humans by multicompartmental analysis. , 1990, The American journal of physiology.

[39]  W. Wiersinga Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism , 2014, Nature Reviews Endocrinology.

[40]  A. Miyauchi,et al.  3,5,3'-Triiodothyronine thyrotoxicosis due to increased conversion of administered levothyroxine in patients with massive metastatic follicular thyroid carcinoma. , 2008, The Journal of clinical endocrinology and metabolism.

[41]  D. Rennie,et al.  Thyroid storm. , 1997, JAMA.

[42]  Johannes W. Dietrich,et al.  SPINA-THYR: A NOVEL SYSTEMS THEORETIC APPROACH TO DETERMINE THE SECRETION CAPACITY OF THE THYROID GLAND , 1997 .

[43]  E B Stear,et al.  Neuroendocrine control of thyroid secretion in living systems: a feedback control system model. , 1968, The Bulletin of mathematical biophysics.

[44]  F. Matsuzuka,et al.  Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease. , 1984, Annals of internal medicine.

[45]  M. Berger,et al.  Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial , 2001, Intensive Care Medicine.

[46]  Volker H. Franz,et al.  Ratios: A short guide to confidence limits and proper use , 2007, 0710.2024.

[47]  A. Bianco,et al.  The History and Future of Treatment of Hypothyroidism , 2016, Annals of Internal Medicine.

[48]  M. Falchi,et al.  Heritability of serum TSH, free T4 and free T3 concentrations: a study of a large UK twin cohort , 2008, Clinical endocrinology.

[49]  K. Nakatani,et al.  Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis. , 1981, The Journal of clinical endocrinology and metabolism.

[50]  Mario Plebani,et al.  Harmonization protocols for thyroid stimulating hormone (TSH) immunoassays: different approaches based on the consensus mean value , 2015, Clinical chemistry and laboratory medicine.

[51]  Johannes W. Dietrich,et al.  A novel de novo mutation in the thyroid hormone receptor-beta gene , 2015 .

[52]  Victor M Montori,et al.  Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. , 2011, Thyroid : official journal of the American Thyroid Association.

[53]  J. DiStefano,et al.  Simulation of post-thyroidectomy treatment alternatives for triiodothyronine or thyroxine replacement in pediatric thyroid cancer patients. , 2012, Thyroid : official journal of the American Thyroid Association.

[54]  E. Fliers,et al.  Pilot study on the assessment of the setpoint of the hypothalamus-pituitary-thyroid axis in healthy volunteers. , 2010, European journal of endocrinology.

[55]  J. DiStefano A model of the normal thyroid hormone glandular secretion mechanism. , 1969, Journal of theoretical biology.

[56]  A. Bianco,et al.  Defending plasma T3 is a biological priority , 2014, Clinical endocrinology.

[57]  J. Hennessey Levothyroxine dosage and the limitations of current bioequivalence standards , 2006, Nature Clinical Practice Endocrinology &Metabolism.

[58]  Johannes W. Dietrich,et al.  Das Refeeding-Syndrom - Eine Literaturübersicht Refeeding Syndrome: A Review of the Literature , 2014 .

[59]  Johannes W. Dietrich,et al.  Integration of Peripheral and Glandular Regulation of Triiodothyronine Production by Thyrotropin in Untreated and Thyroxine-Treated Subjects , 2015, Hormone and Metabolic Research.

[60]  Johannes W. Dietrich,et al.  [Absorption, transport and bio-availability of iodothyronines]. , 2008, Deutsche medizinische Wochenschrift.

[61]  P. Laurberg,et al.  Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: a population-based study. , 2013, European journal of endocrinology.

[62]  S. Rohrer,et al.  Das Refeeding-Syndrom – Eine Literaturübersicht , 2014, Zeitschrift für Gastroenterologie.

[63]  Johannes W. Dietrich,et al.  The AQUA-FONTIS study: protocol of a multidisciplinary, cross-sectional and prospective longitudinal study for developing standardized diagnostics and classification of non-thyroidal illness syndrome , 2008, BMC endocrine disorders.

[64]  Johannes W. Dietrich,et al.  Is pituitary TSH an adequate measure of thyroid hormone-controlled homoeostasis during thyroxine treatment? , 2013, European journal of endocrinology.

[65]  P. Macchia,et al.  Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene. , 1999, The Journal of clinical endocrinology and metabolism.

[66]  P. Laurberg Mechanisms governing the relative proportions of thyroxine and 3,5,3'-triiodothyronine in thyroid secretion. , 1984, Metabolism: clinical and experimental.

[67]  Xiuwen Wu,et al.  Nonthyroidal illness syndrome in enterocutaneous fistulas. , 2013, American journal of surgery.

[68]  A. Bianco,et al.  New insights into the variable effectiveness of levothyroxine monotherapy for hypothyroidism. , 2015, The lancet. Diabetes & endocrinology.

[69]  J. DiStefano,et al.  L-T4 bioequivalence and hormone replacement studies via feedback control simulations. , 2006, Thyroid : official journal of the American Thyroid Association.

[70]  Melvin Khee-Shing Leow,et al.  Hypothalamus–Pituitary–Thyroid Feedback Control: Implications of Mathematical Modeling and Consequences for Thyrotropin (TSH) and Free Thyroxine (FT4) Reference Ranges , 2014, Bulletin of mathematical biology.

[71]  Robert B. DarofL Supplements , 1992, Neurology.

[72]  R. Casamitjana,et al.  Serum free triiodothyronine (T3) to free thyroxine (T4) ratio in treated central hypothyroidism compared with primary hypothyroidism and euthyroidism. , 2011, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.

[73]  Johannes W. Dietrich,et al.  Physiological states and functional relation between thyrotropin and free thyroxine in thyroid health and disease: in vivo and in silico data suggest a hierarchical model , 2013, Journal of Clinical Pathology.

[74]  K. Muroya,et al.  The ratio of serum free triiodothyronine to free thyroxine in children: a retrospective database survey of healthy short individuals and patients with severe thyroid hypoplasia or central hypothyroidism , 2015, Thyroid Research.

[75]  S. Fan,et al.  MON-P112: Low Triiodothyronine Syndrome in Patients with Radiation Enteritis: Risk Factors and Clinical Outcomes an Observational Study , 2016 .

[76]  C. Doré,et al.  A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. , 2002, The American journal of medicine.

[77]  Simon X. Han,et al.  THYROSIM App for Education and Research Predicts Potential Health Risks of Over-the-Counter Thyroid Supplements. , 2016, Thyroid : official journal of the American Thyroid Association.

[78]  T. Wilkin,et al.  The behavior of the triiodothyronine/thyroxine (T3/T4) ratio in normal individuals, and its implications for the regulation of euthyroidism , 1984, Journal of endocrinological investigation.

[79]  J. DiStefano,et al.  Extensions, validation, and clinical applications of a feedback control system simulator of the hypothalamo-pituitary-thyroid axis. , 2008, Thyroid : official journal of the American Thyroid Association.